Literature DB >> 11073156

Inhibition of chemotaxis by organic acids from anaerobes may prevent a purulent response in bacterial vaginosis.

S Al-Mushrif1, A Eley1, B M Jones1.   

Abstract

It has been postulated that certain organic acids produced by the anaerobes associated with bacterial vaginosis (BV) could prevent a purulent response in this infection. Varying concentrations of pure succinic, acetic and lactic acids were incubated in vitro with a monocytic cell line (MonoMac 6). High inhibition of chemotaxis was produced by succinic acid; lower inhibition and no inhibition was shown by acetic acid and lactic acid respectively. Succinic and acetic acids were detected in high concentrations in the vaginal fluid of women with BV and in culture supernates of Prevotella and Mobiluncus spp.; these acids impaired chemotaxis of MonoMac 6 cells in vitro. The vaginal fluids of normal women and the culture supernates of Lactobacillus spp. had no effect on chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073156     DOI: 10.1099/0022-1317-49-11-1023

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  26 in total

Review 1.  Lactate stimulation of gonococcal metabolism in media containing glucose: mechanism, impact on pathogenicity, and wider implications for other pathogens.

Authors:  H Smith; E A Yates; J A Cole; N J Parsons
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands.

Authors:  Paria Mirmonsef; Mohammad R Zariffard; Douglas Gilbert; Hadijat Makinde; Alan L Landay; Greg T Spear
Journal:  Am J Reprod Immunol       Date:  2011-11-08       Impact factor: 3.886

Review 3.  The effects of commensal bacteria on innate immune responses in the female genital tract.

Authors:  Paria Mirmonsef; Douglas Gilbert; Mohammad R Zariffard; Bruce R Hamaker; Amandeep Kaur; Alan L Landay; Greg T Spear
Journal:  Am J Reprod Immunol       Date:  2010-12-09       Impact factor: 3.886

4.  Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis.

Authors:  Amjad N Chaudry; Paul J Travers; Jeffrey Yuenger; Lorraine Colletta; Phillip Evans; Jonathan M Zenilman; Andrew Tummon
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis.

Authors:  B Vitali; F Cruciani; G Picone; C Parolin; G Donders; L Laghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-18       Impact factor: 3.267

Review 6.  The vaginal microbiota, host defence and reproductive physiology.

Authors:  Steven B Smith; Jacques Ravel
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

7.  Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.

Authors:  Luca Laghi; Gianfranco Picone; Federica Cruciani; Patrizia Brigidi; Fiorella Calanni; Gilbert Donders; Francesco Capozzi; Beatrice Vitali
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

8.  Comparison of storage conditions for human vaginal microbiome studies.

Authors:  Guoyun Bai; Pawel Gajer; Melissa Nandy; Bing Ma; Hongqiu Yang; Joyce Sakamoto; May H Blanchard; Jacques Ravel; Rebecca M Brotman
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

Review 9.  The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.

Authors:  Silke Baldewijns; Mart Sillen; Ilse Palmans; Paul Vandecruys; Patrick Van Dijck; Liesbeth Demuyser
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

10.  A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women.

Authors:  Amy McMillan; Stephen Rulisa; Mark Sumarah; Jean M Macklaim; Justin Renaud; Jordan E Bisanz; Gregory B Gloor; Gregor Reid
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.